Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 23/10/2019
SIETES contiene 92827 citas

 
 
 1 a 20 de 2742 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Anónimo. GSK cuts back operations in Africa. DIA Daily 2018:1. [Ref.ID 102445]
2.Enlace a cita original Cita con resumen
Anónimo. Access to medicines—the status quo is no longer an option. Lancet 2016;388:1250. [Ref.ID 100699]
3. Cita con resumen
Anónimo. UN panel questions free market approach to R&D for medicines. DIA Daily 2016:1. [Ref.ID 100664]
4. Cita con resumen
Crow D. Poorer countries need rapid access to generic drugs, UN says. Financial Times 2016:1. [Ref.ID 100663]
5. Cita con resumen
Schroeder LF, Guarner J, Eibireer A, Castle PE, Amukele TK. Time for a model list of essential diagnostics. N Engl J Med 2016;374:2511-4. [Ref.ID 100451]
6. Cita con resumen
Owen J. Pay drug companies $1bn for each new antibiotic, says report. BMJ 2016;353:i2863. [Ref.ID 100427]
7.Enlace a cita original Cita con resumen
González R, Sevene E, Jagoe G, Slutsker L, Menéndez C. A public health paradox: the women most vulnerable to malaria are the least protected. PLOS Medicine 2016:3 de mayo. [Ref.ID 100350]
9. Cita con resumen
Taylor P, Nutt D, Fortson R, Henderson G, on behalf of DrugScience. Ketamine—the real perspective. Lancet 2016;387:1271-2. [Ref.ID 100277]
10.Enlace a cita original Cita con resumen
NCD Risk FactorCollaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants. Lancet 2016;387:1513-30. [Ref.ID 100226]
11. Cita con resumen
Anónimo. GSK conducting internal review of bribery allegations In Yemen. DIA Daily 2016:1. [Ref.ID 100120]
12. Cita con resumen
Anónimo. GSK to stop seeking drug patents In 85 of the poorest countries. DIA Daily 2016:1. [Ref.ID 100105]
13.Tiene citas relacionadas Cita con resumen
Sutter RW, Bahl S, Deshpande JM, Verma H, Ahmad M, Venugopal P, Rao JV, Agarkhedkar S, Lalwani SK, Kunwar A, Sethi R, Takane M, Mohanty L, Chatterjee A, John TJ, Jafari H, Aylward RB. Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention. an open-label, randomised controlled trial. Lancet 2015;386:2413-21. [Ref.ID 99767]
14. Cita con resumen
Anónimo. Drugs past their expiration date. Med Lett Drugs Ther 2015;57:164-5. [Ref.ID 99690]
15. Cita con resumen
Smyth A, Teo KK, Rangarajan S, O'Donnell M, Zhang X, Rana P, Leong DP, Dagenais G, Seron P, Rosengren A, Schutte AE, Lopez-Jaramillo P, Oguz A, Chifamba J, Díaz R, Lear S, Avezum A, Kumar R, Mohan V, Szuba A, Wei L, Yang W, Jian B, McKee M, Yusuf S, PURE Investigators. Alcohol consumption and cardiovascular disease, cancer, injury, admission to hospital, and mortality: a prospective cohort study. Lancet 2015;386:1945-54. [Ref.ID 99672]
16. Cita con resumen
Anónimo. What next for the malaria RTS,S vaccine candidate?. Lancet 2015;386:1708. [Ref.ID 99666]
17. Cita con resumen
Maurice J. And then there were two…polio-endemic countries. Lancet 2015;386:1521-2. [Ref.ID 99659]
18. Cita con resumen
Anónimo. Global prescription drug spending expected to increase 30% by 2020. DIA Daily 2015:18 de noviembre. [Ref.ID 99645]
19.Tiene citas relacionadas Cita con resumen
Simmons CP. A candidate dengue vaccine walks a tightrope. N Engl J Med 2015;373:1263-4. [Ref.ID 99601]
20.Tiene citas relacionadas Cita con resumen
Henao-Restrepo AM, Longini IM, Egger M, Dean NE, Edmunds WJ, Camacho A, Carroll MW, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Hossmann S, Kondé GN, Soumah A, Trelle S, Vicari AS, Watson CH, Kieny MP, Rottingen J-A. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet 2015;386:857-66. [Ref.ID 99512]
Seleccionar todas
 
 1 a 20 de 2742 siguiente >>